Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tretinoin with TPM versus commercial tretinoin versus vehicle for acne vulgaris
ACTRN12613000756729Phase 2Completed
- Sponsor
- Avecho Biotechnology
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, single-blind trial of tretinoin in acne vulgaris (3 arms), sponsored by Avecho Biotechnology. Primary endpoints: Mean absolute change in total acne lesion count and Successful outcome on global acne grading scale. Started Jul 2013; status: completed.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ACTRN12613000756729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000756729.